Wednesday, September 16, 2026

From Raindrops to Bass Drops: 2024 World DJ Festival Rocks Seoul

The World DJ Festival successfully concluded in...

Wang Yi of China Meets North Korean Delegation, Stresses ‘Need for Enhanced Strategic Communication and Tactical Cooperation Between the Two Nations’

A North Korean Workers' Party delegation visiting...

No Mention of U.S. or South Korea as Kim Jong Un Reviews First Half of 2025

North Korea's recent plenary meeting showed caution, avoiding discussions on South Korea and the U.S., while focusing on internal achievements.

Health

Celltrion Submits U.S. Phase 4 IND for High-Dose 240 mg Zymfentra

Celltrion has submitted a U.S. Phase 4 trial application to support the use of a higher 240 mg dose of Zymfentra, aiming to expand personalized dosing options and strengthen the drug's position in the U.S. market.

Blood Proteins May Offer Clues to Alzheimer’s Antibody Treatment Benefits and Side-Effect Risks

A South Korean study found that blood levels of complement proteins C1q and C3 may help predict amyloid reduction and ARIA risk in patients receiving lecanemab, though larger studies are needed.

Pentrym Confirms Combination Benefits With Existing Cancer Drugs, Targets “False Resistance”

Pentrym is testing whether targeting the tumor microenvironment alongside existing cancer drugs can overcome “false resistance” and improve treatment effectiveness.

YH42946: The Promising HER2 Targeted Oral Treatment Set to Transform Cancer Care in 2026

Yuhan Corporation will reveal early results of its oral HER2-targeted therapy candidate 'YH42946' in clinical trials by year-end.

SK Biopharm Achieves MSCI ESG AAA Rating for 3rd Consecutive Year: What It Means for the Pharma Industry

SK Biopharm has achieved the highest AAA rating in MSCI's ESG evaluation for three consecutive years.
Latest

PenetriumBioScience Files U.S. FDA IND for Phase 2a Trial in Advanced Solid Tumors

Penitrium Bioscience enters Phase 2a clinical trials in the U.S. for its cancer drug candidate 'Penitrium.'

DigmBio Launches Preclinical Research for Alzheimer’s Drug DM3159: What You Need to Know

DigmBio has been selected for the R&D project to advance preclinical research on the Alzheimer's drug candidate DM3159.

How DEEPNOID’s AxonFlow is Enhancing Hospital Operations: A Comprehensive Guide

DEEPNOID has received FDA approval for its remote reading platform, AxonFlow, aiding hospitals and screening centers.

SkyLabs’ CART BP Pro: The Revolutionary Ring-Style Blood Pressure Monitor Set to Gain FDA Approval in 2027

Skylabs accelerates its U.S. market entry by starting clinical trials for its ring-shaped blood pressure monitor, seeking FDA approval.

5 Key Research Findings on Dr. Noon CVD: A Game-Changer for Cardiovascular Disease Prevention

Mediwhale presented five abstracts on its AI-based cardiovascular risk assessment solution, Dr. Noon CVD, at the ASPC conference.

“Improved Survival Rates”… Carboplatin Combination Therapy Shows Benefit in Triple-Negative Breast Cancer

Adding carboplatin to chemotherapy for operable triple-negative breast cancer reduces recurrence risk and improves survival, study finds.

Inventage Lab Selected for Global TIPS Program, Accelerating Late-Stage Development of Addiction Treatment

Inventis Lab's long-acting drug IVL3004 for addiction treatment has been selected for the Global TIPS research project by the Ministry of SMEs.

Bukwang Pharm Signs Export Agreement With Thailand’s Pacific Healthcare for Dexid

Bukwang Pharmaceutical signs exclusive export contract for diabetes treatment 'Dexide' with Pacific Healthcare in Thailand.

Huawei Unveils OpenPangu 2.0 Pro: Is This the Future of AI with 505 Billion Parameters?

Huawei accelerates its AI ecosystem expansion by revealing the source of its massive AI model with over 500 billion parameters.

AI-Driven Preclinical Platform: Revolutionizing Infectious Disease Treatment and Vaccine Development by 2030

An AI-based digital preclinical platform is being developed to expedite the creation of treatments and vaccines for emerging infectious diseases.

Revolutionizing Stroke Treatment: JLK’s AI Solution in 22 Hospitals

JLK, a medical AI firm, initiates a large-scale clinical study on stroke AI imaging solutions across 22 hospitals in Korea.

What Makes QP101 the Next Big Breakthrough in Cancer Treatment?

QP101, a next-gen antibody-drug conjugate by Curient, is highlighted as a notable drug development strategy by AACR.

Hong Seong-ho of Seoul St. Mary’s Hospital Becomes First in Asia-Pacific to Perform 1,000 Single-Port Robotic Urologic Surgeries

A South Korean medical team achieved 1,000 single-port robotic surgeries in urology, led by Professor Hong Seong-ho.

Celltrion accelerates mechanism diversification strategy, expands autoimmune disease portfolio

Celltrion accelerates the development of biosimilars for autoimmune disease treatments, expanding its portfolio for long-term growth.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.